AR030504A1 - Peptidos ciclicos selectivos - Google Patents

Peptidos ciclicos selectivos

Info

Publication number
AR030504A1
AR030504A1 ARP010104096A ARP010104096A AR030504A1 AR 030504 A1 AR030504 A1 AR 030504A1 AR P010104096 A ARP010104096 A AR P010104096A AR P010104096 A ARP010104096 A AR P010104096A AR 030504 A1 AR030504 A1 AR 030504A1
Authority
AR
Argentina
Prior art keywords
peptides
selective cycle
cycle peptides
selective
bridges
Prior art date
Application number
ARP010104096A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR030504A1 publication Critical patent/AR030504A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Péptidos ciclados mediante puentes disulfuro o puentes lactama, con actividad agonista para el receptor de la melanocortina-4 (MCR4-R), de utilidad para el tratamiento de la obesidad.
ARP010104096A 2000-08-30 2001-08-28 Peptidos ciclicos selectivos AR030504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22918400P 2000-08-30 2000-08-30

Publications (1)

Publication Number Publication Date
AR030504A1 true AR030504A1 (es) 2003-08-20

Family

ID=22860145

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010104096A AR030504A1 (es) 2000-08-30 2001-08-28 Peptidos ciclicos selectivos
ARP070102336A AR061422A2 (es) 2000-08-30 2007-05-30 Peptidos ciclicos selectivos, procedimiento de preparacion, composicion farmaceutica que los comprende, y uso de los mismos en la preparacion de medicamentos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP070102336A AR061422A2 (es) 2000-08-30 2007-05-30 Peptidos ciclicos selectivos, procedimiento de preparacion, composicion farmaceutica que los comprende, y uso de los mismos en la preparacion de medicamentos

Country Status (35)

Country Link
US (1) US7045591B2 (es)
EP (1) EP1315750B1 (es)
JP (1) JP4217069B2 (es)
KR (1) KR100483300B1 (es)
CN (1) CN100491396C (es)
AR (2) AR030504A1 (es)
AT (1) ATE353918T1 (es)
AU (2) AU2001284026B2 (es)
BR (1) BR0113637A (es)
CA (1) CA2420058C (es)
CY (1) CY1106562T1 (es)
CZ (1) CZ2003584A3 (es)
DE (1) DE60126624T2 (es)
DK (1) DK1315750T3 (es)
EC (1) ECSP034503A (es)
ES (1) ES2280393T3 (es)
HR (1) HRP20030126B1 (es)
HU (1) HUP0303078A3 (es)
IL (2) IL154575A0 (es)
JO (1) JO2454B1 (es)
MA (1) MA27681A1 (es)
MX (1) MXPA03001721A (es)
MY (1) MY137457A (es)
NO (1) NO20030916D0 (es)
NZ (1) NZ523989A (es)
PA (1) PA8527201A1 (es)
PE (1) PE20020483A1 (es)
PL (1) PL366630A1 (es)
PT (1) PT1315750E (es)
RU (1) RU2239642C1 (es)
SI (1) SI1315750T1 (es)
TW (1) TWI248941B (es)
WO (1) WO2002018437A2 (es)
YU (1) YU15603A (es)
ZA (1) ZA200301015B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534850A (ja) * 2001-07-12 2004-11-18 メルク　エンド　カムパニー　インコーポレーテッド 強力な選択的メラノコルチン−４受容体アゴニストとしての環状ペプチド
CA2462200A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7655658B2 (en) 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
AU2003248888A1 (en) 2002-07-09 2004-01-23 Palatin Technologies, Inc. Peptide composition for treatment of sexual dysfunction
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
MXPA05011830A (es) 2003-05-09 2006-01-26 Novo Nordisk As Peptidos para uso en el tratamiento de la obesidad.
JP2007524584A (ja) * 2003-05-09 2007-08-30 ノボ　ノルディスク　アクティーゼルスカブ 肥満の治療に使用するペプチド
CA2527881A1 (en) * 2003-06-19 2005-01-06 Eli Lilly And Company Uses of melanocortin-3 receptor (mc3r) agonist peptides
CA2530024A1 (en) * 2003-06-19 2005-01-06 Eli Lilly And Company Melanocortin receptor 4(mc4) agonists and their uses
US7084111B2 (en) 2003-06-23 2006-08-01 University Of Florida Research Foundation, Inc. Melanocortin receptor templates, peptides, and use thereof
KR20060089874A (ko) * 2003-09-30 2006-08-09 노보 노르디스크 에이/에스 신규 멜라노코르틴 수용체 작용제
US7550602B1 (en) * 2004-01-14 2009-06-23 Palatin Technologies, Inc. Small molecule compositions for sexual dysfunction
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
WO2005102377A1 (en) * 2004-03-29 2005-11-03 Eli Lilly And Company Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
ES2358352T3 (es) * 2004-04-08 2011-05-09 Astellas Pharma Inc. Compuesto ws727713.
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
CN101052649A (zh) * 2004-11-04 2007-10-10 诺和诺德公司 用于治疗肥胖的肽类
US20080039387A1 (en) * 2004-11-04 2008-02-14 Novo Nordisk A/S Novel Peptides for Use in the Treatment of Obesity
EP1809666A2 (en) * 2004-11-04 2007-07-25 Novo Nordisk A/S Peptides for use in the treating obesity
EP1812471A2 (en) * 2004-11-04 2007-08-01 Novo Nordisk A/S Peptides for use in treating of obesity
BRPI0610955A2 (pt) * 2005-05-31 2010-08-03 Yissum Res Dev Co análogos de hormÈnio estimulador de melanocortina ((alfa)msh) ciclizado de estrutura
WO2006135930A2 (en) * 2005-06-13 2006-12-21 Nastech Pharmaceutical Company Inc. Transmucosal delivery of peptide derivatives
US20070025902A1 (en) * 2005-07-15 2007-02-01 3M Innovative Properties Company Recovery of fluorinated carboxylic acid from adsorbent particles
US20080015304A1 (en) 2006-07-13 2008-01-17 Klaus Hintzer Aqueous emulsion polymerization process for producing fluoropolymers
GB2430437A (en) * 2005-09-27 2007-03-28 3M Innovative Properties Co Method of making a fluoropolymer
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
CA2673229A1 (en) * 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Methods for the synthesis of cyclic peptides
KR101500018B1 (ko) * 2007-02-16 2015-03-06 쓰리엠 이노베이티브 프로퍼티즈 캄파니 물로부터 불소화합물계 물질을 제거하는 시스템 및 방법
US20080264864A1 (en) 2007-04-27 2008-10-30 3M Innovative Properties Company PROCESS FOR REMOVING FLUORINATED EMULSIFIER FROM FLUOROPOLMER DISPERSIONS USING AN ANION-EXCHANGE RESIN AND A pH-DEPENDENT SURFACTANT AND FLUOROPOLYMER DISPERSIONS CONTAINING A pH-DEPENDENT SURFACTANT
CA2689016C (en) * 2007-05-25 2014-08-12 Ipsen Pharma S.A.S. Melanocortin receptor ligands modified with hydantoin
US8258313B2 (en) 2007-07-19 2012-09-04 Tokuyama Corporation Compound having hydantoin ring and method of producing the same
AU2009228637B2 (en) * 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives
RU2503660C2 (ru) 2008-03-27 2014-01-10 Грюненталь Гмбх Замещенные производные 4-аминоциклогексана
NZ590254A (en) 2008-06-09 2012-07-27 Palatin Technologies Inc Melanocortin receptor-specific cyclic peptides for treatment of sexual dysfunction
WO2009151383A1 (en) * 2008-06-09 2009-12-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for the treatment of obesity and other diseases associated with melanocortin receptor function
CN102458436B (zh) 2009-06-08 2015-06-03 帕拉丁科技公司 黑皮质素受体特异性肽
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EP2504351A4 (en) 2009-11-23 2013-10-30 Palatin Technologies Inc MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
BR112012011787B1 (pt) 2009-11-23 2022-03-03 Palatin Technologies, Inc Peptídeo cíclico e composição farmacêutica
RU2725150C2 (ru) * 2013-03-15 2020-06-30 Ритм Фармасьютикалз, Инк. Пептидные композиции
GB201416351D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Heterocyclic derivatives
GB201416352D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
EA201790699A1 (ru) * 2014-09-26 2017-10-31 Байер Фарма Акциенгезельшафт Стабилизированные производные адреномедуллина и их применение
US11542302B2 (en) 2015-10-15 2023-01-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Modulators of melanocortin receptors for the treatment of depression and anxiety
WO2017066754A1 (en) 2015-10-15 2017-04-20 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for the treatment of depression and anxiety
WO2018074999A1 (en) * 2016-10-17 2018-04-26 The Arizona Board Of Regents On Behalf Of The University Of Arizona Novel modulators of melanocortin receptors for the treatment of depression and anxiety
US10899793B2 (en) 2016-05-27 2021-01-26 Regents Of The University Of Minnesota Melanocortin ligands and methods of use thereof
US11124541B2 (en) 2016-10-18 2021-09-21 Regents Of The University Of Minnesota Chimeric melanocortin ligands and methods of use thereof
CN106496005B (zh) * 2016-10-20 2019-04-09 上海毕得医药科技有限公司 一种4-(4-氯苯基)环己酮的合成方法
CN106496008A (zh) * 2016-10-20 2017-03-15 上海毕得医药科技有限公司 一种合成4‑(4‑氯苯基)环己酮的方法
US10745444B2 (en) * 2017-04-17 2020-08-18 National Tsing Hua University Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
US11332499B2 (en) 2018-08-16 2022-05-17 Regents Of The University Of Minnesota Cyclic peptides and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811391A (en) 1994-08-25 1998-09-22 Cytel Corporation Cyclic CS-1 peptidomimetics, compositions and methods of using same
US5858972A (en) 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
KR100558131B1 (ko) 1999-03-29 2006-03-10 더 프록터 앤드 갬블 캄파니 멜라노코르틴 수용체 리간드를 함유하는 약제학적 조성물및 멜라노코르틴 수용체 리간드를 함유하는 약제의제조방법

Also Published As

Publication number Publication date
WO2002018437A2 (en) 2002-03-07
KR100483300B1 (ko) 2005-04-15
EP1315750B1 (en) 2007-02-14
US20020143141A1 (en) 2002-10-03
CY1106562T1 (el) 2012-01-25
US7045591B2 (en) 2006-05-16
AU2001284026B2 (en) 2007-03-01
YU15603A (sh) 2006-05-25
TWI248941B (en) 2006-02-11
AU8402601A (en) 2002-03-13
BR0113637A (pt) 2004-02-25
MA27681A1 (fr) 2006-01-02
RU2239642C1 (ru) 2004-11-10
DE60126624T2 (de) 2007-11-22
CN100491396C (zh) 2009-05-27
CA2420058C (en) 2009-04-07
IL154575A0 (en) 2003-09-17
CN1451017A (zh) 2003-10-22
SI1315750T1 (sl) 2007-06-30
HUP0303078A3 (en) 2012-02-28
NO20030916L (no) 2003-02-27
HUP0303078A2 (hu) 2003-12-29
DE60126624D1 (de) 2007-03-29
ZA200301015B (en) 2004-05-05
ECSP034503A (es) 2003-04-25
IL154575A (en) 2008-12-29
MXPA03001721A (es) 2003-05-27
ES2280393T3 (es) 2007-09-16
EP1315750A2 (en) 2003-06-04
KR20030061788A (ko) 2003-07-22
PA8527201A1 (es) 2002-04-25
NO20030916D0 (no) 2003-02-27
PL366630A1 (en) 2005-02-07
JP2004507558A (ja) 2004-03-11
ATE353918T1 (de) 2007-03-15
PT1315750E (pt) 2007-05-31
JP4217069B2 (ja) 2009-01-28
JO2454B1 (en) 2008-10-09
WO2002018437A3 (en) 2002-06-06
DK1315750T3 (da) 2007-06-11
AR061422A2 (es) 2008-08-27
NZ523989A (en) 2004-08-27
MY137457A (en) 2009-01-30
CA2420058A1 (en) 2002-03-07
PE20020483A1 (es) 2002-06-06
CZ2003584A3 (cs) 2003-08-13
HRP20030126A2 (en) 2005-10-31
HRP20030126B1 (en) 2009-01-31

Similar Documents

Publication Publication Date Title
AR030504A1 (es) Peptidos ciclicos selectivos
NO20035245D0 (no) Grunnleggende Wi-Fi-arkitektur for 802.11-nettverk
NO983431D0 (no) Anti-kl°emidler
BRPI0517973A (pt) método para purificar o fsh
DK1446394T3 (da) Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer
CY1107254T1 (el) Μη πεπτιδικοι ανταγωνιστες της ωραδυκινινης και φαρμακευτικες συνθεσεις αυτων
AR016981A2 (es) Polipeptidos sinteticos
EA200700659A1 (ru) Циклизация пептидов
DE69938935D1 (de) Zyklische conotoxin-peptide
BRPI0417992A (pt) método para purificar fsh
CR8167A (es) Procedimiento para la preparacion de derivados de espirobenzoacepina sustituida no peptidica
WO2004056763A3 (en) Novel glucagon antagonists
DK1511764T3 (da) Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor
ES1051709Y (es) Fosa para la descomposicion de cadaveres animales.
UY26913A1 (es) Péptidos cíclicos selectivos
ES1052228Y (es) Paracaidas de cilindro.
ES1051900Y (es) Util para el tensado de alambre.
ES1051969Y (es) Pieza para la construccion con material aislante incorporado.
ES1052613Y (es) Martillo para la aplicacion de marchamos.
ITTO20020116U1 (it) ,,portabastoni, specialmente per stampelle,,.
ES1048776Y (es) Aparato para alargar el pene.
BR0314031A (pt) Tratamento de rinite não-alérgica por inibidores seletivos de fosfodiesterase 4
NO20035107D0 (no) Antistoffer som er spesifikke for CD44V6
ES1049916Y (es) Dispositivo para el armado de butacas.
ES1052831Y (es) Cilindro de ruleta.

Legal Events

Date Code Title Description
FG Grant, registration